Cheryl Schwartz

Cheryl Schwartz is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as Senior Vice President and U.S. Rare Disease Business Unit Lead at Takeda, along with overseeing U.S. Commercial Operations. Prior to this role, Cheryl Schwartz held the position of Senior Vice President at EMD Serono, Inc., leading the Endocrinology, HIV & Reproductive Health Business Unit. Additionally, Cheryl Schwartz was Director of Worldwide Commercial Development at Pfizer and served as a Global Health Fellow at USAID, contributing expertise from Pfizer to the initiative in South Africa.